[Zurück]
Dr. Astrid Slany, Privatdoz.
T: +43-1-4277-52315
Grunt, T. W., Slany, A., Semkova, M., Colomer, R., Luz Lopez-Rodriguez, M., Wuczkowski, M., Wagner, R., Gerner, C., & Stuebiger, G. (2020). Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer. Scientific Reports, 10(1), [14877]. https://doi.org/10.1038/s41598-020-71491-z
Tchaikovsky, A., Schoeberl, A., Schueffl, H., Raab, A., Emin, S., Slany, A., Heffeter, P., Koellensperger, G., & Swart, C. (2020). Quantification of ferritin-bound iron in murine samples for Alzheimer's disease studies using species-specific isotope dilution mass spectrometry. Metrologia: international journal of pure and applied metrology, 57(4), [042101]. https://doi.org/10.1088/1681-7575/ab8c9f
Muqaku, B., Pils, D., Mader, J. C., Aust, S., Mangold, A., Muqaku, L., Slany, A., Del Favero, G., & Gerner, C. (2020). Neutrophil Extracellular Trap Formation Correlates with Favorable Overall Survival in High Grade Ovarian Cancer. Cancers, 12(2), [505]. https://doi.org/10.3390/cancers12020505
Slany, A., Wagner, R., Stübiger, G., Semkova, M., Colomer, R., López-Rodríguez, M. L., Gerner, C., & Grunt, T. W. (2019). Hit one to eliminate all during cancer treatment: The crucial role of fatty acid synthase (FASN) in ovarian cancer (OC) growth. in JNTERNATIONAL JOURNAL OF MOLECULAR MEDICINE: Proceedings of the Abstracts of The 24th World Congress on Advances in Oncology and 24th International Symposium on Molecular Medicine (Band 44, S. 7)
Gerner, M. C., Niederstätter, L., Ziegler, L., Bileck, A., Slany, A., Janker, L., Schmidt, R. L. J., Gerner, C., Del Favero, G., & Schmetterer, K. G. (2019). Proteome Analysis Reveals Distinct Mitochondrial Functions Linked to Interferon Response Patterns in Activated CD4+and CD8+T Cells. Frontiers in Pharmacology, 10, [727]. https://doi.org/10.3389/fphar.2019.00727
Slany, A., & Janker, L. (2019). Tackling an incurable blood cancer. ASBMB Today, 16.
Janker, L., Mayer, R. L., Bileck, A., Kreutz, D., Mader, J. C., Utpatel, K., Heudobler, D., Agis, H., Gerner, C., & Slany, A. (2019). Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia. Molecular & cellular proteomics : MCP, 18(5), 936-953. https://doi.org/10.1074/mcp.RA119.001390
Schuster, D., Janker, L., Pfisterer, N., Redl, E., Slany, A., Feichtenschlager, T., & Gerner, C. (2019). Contribution of inflamed fibroblasts to the disease phenotype of ulcerative colitis. Postersitzung präsentiert bei Proteomics and its Application to Translational and Precision Medicine (D3), Stockholm, Schweden.
Slany, A., Janker, L., Mayer, R. L., Bileck, A., Kreutz, D., Mader, J., Utpatel, K., Heudobler, D., Agis, H., & Gerner, C. (2019). An in-depth proteome profiling analysis of primary human myeloma cells shows that adaptations to hypoxia are associated with multiple myeloma disease progression. Postersitzung präsentiert bei Proteomics in Cell Biology and Disease Mechanisms, Heidelberg, Deutschland.
Gerner, C., Janker, L., Niederstätter, L., Gerner, M. C., Schmetterer, K. G., Del Favero, G., & Slany, A. (2019). Mitochondrial functions and dysfunctions in inflammatory stimulated CD4+ T cells and B cells from chronic lymphocytic leukemia patients point to molecular mechanisms of chronic diseases.. Postersitzung präsentiert bei Proteomics in Cell Biology and Disease Mechanisms, Heidelberg, Deutschland.
Schwarzmeier, J., Gerner, C., Slany, A., Mayer, R. L., Gerner, M. C., & Reichle, A. (2018). Aging von Lymphozyten als mögliche Prädisposition zur chronisch lymphatischen Leukämie? Proteomische und metabolomische Analysen. Postersitzung präsentiert bei JAHRESTAGUNG der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 2018 , Wien, Österreich.
Kreutz, D., Sinthuvanich, C., Bileck, A., Janker, L., Muqaku, B., Slany, A., & Gerner, C. (2018). Curcumin exerts its antitumor effects in a context dependent fashion. Journal of Proteomics, 182, 65-72. https://doi.org/10.1016/j.jprot.2018.05.007
Kreutz, D., Sinthuvanich, C., Bileck, A., Janker, L., Slany, A., & Gerner, C. (2018). Curcumin exerts its antitumor effects in a context dependent fashion. in Book of Abstracts
Niederstätter, L., Gerner, M. C., Bileck, A., Slany, A., Schmetterer, K., & Gerner, C. (2018). Immune cells strategies for coping with metabolic stress as cancer model. in Book of Abstracts
Muqaku, B., Eisinger, M., Meier-Menches, S. M., Tahir, A., Pukrop, T., Haferkamp, S., Slany, A., Reichle, A., & Gerner, C. (2018). Reprogramming of organ functions via systemic calcium mobilization. in Book of Abstracts
Mayer, R. L., Schwarzmeier, J. D., Gerner, M. C., Bileck, A., Mader, J. C., Meier-Menches, S. M., Gerner, S. M., Schmetterer, K. G., Pukrop, T., Reichle, A., Slany, A., & Gerner, C. (2018). Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia. Molecular and Cellular Proteomics, 17(2), 290-303. [UNSP RA117.000425]. https://doi.org/10.1074/mcp.RA117.000425
Mayer, R. L., Slany, A., Bileck, A., Schwarzmeier, J., & Gerner, C. (2017). Combined Proteomics and Metabolomics Approach for the Investigation of Metabolic Deregulations in Chronic Lymphocytic Leukemia. Postersitzung präsentiert bei HUPO2017, Dublin, Irland.
Janker, L., Slany, A., Reichle, A., & Gerner, C. (2017). In-depth proteome-profiling to evaluate a novel combinatory metronomic treatment for therapy-resistant multiple myeloma patients. Postersitzung präsentiert bei HUPO2017, Dublin, Irland.
Slany, A., Mayer, R. L., Tahir, A., Bileck, A., Mader, J., Walder, G., Agis, H., & Gerner, C. (2017). Multiple myeloma associated bone marrow fibroblasts characterized by multi-omics analyses including proteomics, metabolomics and eicosadomics. Postersitzung präsentiert bei HUPO2017, Dublin, Irland.
Janker, L., Slany, A., Reichle, A., & Gerner, C. (2017). In-depth proteome-profiling to evaluate a novel combinatory metronomic treatment for therapy-resistant multiple myeloma patients. Postersitzung präsentiert bei APRS 2017, Graz, Österreich.

High-resolution mass spectrometry-based proteomics applied in cancer research

Astrid Slany (Invited speaker)
5 Nov 2020

Aktivität: Vorträge › Vortrag › Science to Science

Die treibenden Kräfte des Myeloms

Astrid Slany (Invited speaker)
17 Okt 2020

Aktivität: Vorträge › Vortrag › Science to Science

Multi-omics analyses of cancer development and progression under special consideration of the tumor microenvironment

Astrid Slany (Invited speaker)
25 Mai 2020

Aktivität: Vorträge › Vortrag › Science to Science

Analytical tools and strategies to get insights into tumor pathophysiologies

Astrid Slany (Invited speaker)
14 Nov 2019

Aktivität: Vorträge › Vortrag › Science to Science

Identifying key players responsible for local and systemic changes in colonic tissue and plasma samples of ulcerative colitis patients

Lukas Janker (Vortragende*r), Dina Schuster (Autor*in), Laura Niederstätter (Autor*in), Nikolaus Pfisterer (Autor*in), Astrid Slany (Autor*in), Thomas Feichtenschlager (Autor*in), Christopher Gerner (Autor*in)
18 Sep 2019

Aktivität: Vorträge › Vortrag › Science to Science

Multi-omics analysis to reveal immune evasion and metabolic strategies of tumor cells

Astrid Slany (Invited speaker)
16 Jul 2019

Aktivität: Vorträge › Vortrag › Science to Science

Application of in-depth proteome profiling based on high resolution mass spectrometry to reveal patho-physiological mechanisms

Astrid Slany (Invited speaker)
24 Apr 2019

Aktivität: Vorträge › Vortrag › Science to Science

In-depth proteome profiling of primary human myeloma cells: new insights into hypoxia driven metabolic, anti-apoptotic and immune evasion strategies

Astrid Slany (Vortragende*r), Lukas Janker (Autor*in), Rupert Laurenz Mayer (Autor*in), Andrea Bileck (Autor*in), Dominique Kreutz (Autor*in), Johanna Mader (Autor*in), Hermine Agis (Autor*in), Christopher Gerner (Autor*in)
29 Aug 2018

Aktivität: Vorträge › Vortrag › Science to Science

APPLICATION OF MASS SPECTROMETRY-BASED PROTEOMICS FOR BIOANALYSIS

Astrid Slany (Invited speaker)
2 Jul 2018

Aktivität: Vorträge › Vortrag › Science to Science

Curcumin exerts its antitumor effects in a context dependent fashion

Lukas Janker (Vortragende*r), Dominique Kreutz (Autor*in), Chomdao Sinthuvanich (Autor*in), Andrea Bileck (Autor*in), Astrid Slany (Autor*in), Christopher Gerner (Autor*in)
4 Mai 2018

Aktivität: Vorträge › Vortrag › Science to Science

Aging-related proteome alterations in B cells may predispose for chronic lymphocytic leukemia

Rupert Laurenz Mayer (Vortragende*r), Astrid Slany (Autor*in), Andrea Bileck (Autor*in), Johanna Mader (Autor*in), Samuel Matthias Meier (Autor*in), Tobias Pukrop (Autor*in), Albrecht Reichle (Autor*in), Josef D. Schwarzmeier (Autor*in), Christopher Gerner (Autor*in)
6 Sep 2017

Aktivität: Vorträge › Vortrag › Science to Science

Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma

Besnik Muqaku (Vortragende*r), Martin Eisinger (Autor*in), Samuel Matthias Meier (Autor*in), Ammar Tahir (Autor*in), Tobias Pukrop (Autor*in), Sebastian Haferkamp (Autor*in), Astrid Slany (Autor*in), Albrecht Reichle (Autor*in), Christopher Gerner (Autor*in)
6 Sep 2017

Aktivität: Vorträge › Vortrag › Science to Science

Combinatory shotgun proteomics and shotgun eicosadomics study of platelets activated by calcium mobilization

Christopher Gerner (Vortragende*r), Ammar Tahir (Autor*in), Rupert Laurenz Mayer (Autor*in), Marie L. Boehm (Autor*in), Andrea Bileck (Autor*in), Besnik Muqaku (Autor*in), Albrecht Reichle (Autor*in), Astrid Slany (Autor*in)
3 Apr 2017

Aktivität: Vorträge › Vortrag › Science to Science

Contribution of human fibroblasts and endothelial cells to the Hallmarks of Inflammation as determined by proteome profiling

Astrid Slany (Invited speaker)
31 Mär 2016

Aktivität: Vorträge › Vortrag › Andere

Contribution of human fibroblasts and endothelial cells to the Hallmarks of Inflammation as determined by proteome profiling

Astrid Slany (Vortragende*r)
24 Feb 2016

Aktivität: Vorträge › Vortrag › Andere

New insights into tumor biology and drug effects in multiple myeloma obtained by proteome profiling

Astrid Slany (Invited speaker)
17 Nov 2015

Aktivität: Vorträge › Vortrag › Andere

Proteomics in cancer research

Astrid Slany (Invited speaker)
15 Jan 2015

Aktivität: Vorträge › Vortrag › Andere

Comparative proteome profiling and targeted proteomics-based drug evaluation

Astrid Slany (Vortragende*r)
2 Jul 2014

Aktivität: Vorträge › Vortrag › Andere

Characterization of the tumor-promoting effect of stromal cells in multiple myeloma by proteome profiling

Astrid Slany (Vortragende*r)
2 Sep 2013

Aktivität: Vorträge › Vortrag › Andere

Quantitative analysis of glycoconjugates in the context of biomarker research

Astrid Slany (Autor*in)
30 Nov 2012

Aktivität: Vorträge › Vortrag › Andere

TARGETED PROTEOMICS APPROACHES FOR MONITORING CYTOKINE SECRETION FOLLOWING INFLAMMATORY STIMULATION

Astrid Slany (Autor*in)
14 Okt 2012

Aktivität: Vorträge › Vortrag › Andere

Characterization of tumor-stroma interactions by means of marker proteins in multiple myeloma

Astrid Slany (Autor*in)
24 Sep 2012

Aktivität: Vorträge › Vortrag › Andere

Institut für Analytische Chemie

Währinger Straße 38
1090 Wien
Zimmer: 1224

T: +43-1-4277-52315
F: +43-1-4277-852315

astrid.slany@univie.ac.at